AMY MORGAN: Open Payments
NPI 1396254488 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 18 payments from 8 companies in 2025. Trend: 2023 $750 · 2024 $371 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $178 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Eisai Inc. | 2 | $38 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| BeOne Medicines USA, Inc. | 1 | $28 |
| Aveo Pharmaceuticals, Inc. | 1 | $21 |
| Iovance Biotherapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: KISQALI, PLUVICTO, Lenvima, DARZALEX, TEVIMBRA, LUTATHERA, JEMPERLI, FOTIVDA.
Industry payments across FL — which companies pay providers there.
